Elanco Animal Health Revenue 2016-2024 | ELAN

Elanco Animal Health annual/quarterly revenue history and growth rate from 2016 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Elanco Animal Health revenue for the quarter ending December 31, 2024 was $1.020B, a 1.45% decline year-over-year.
  • Elanco Animal Health revenue for the twelve months ending December 31, 2024 was $4.439B, a 0.5% increase year-over-year.
  • Elanco Animal Health annual revenue for 2024 was $4.439B, a 0.5% increase from 2023.
  • Elanco Animal Health annual revenue for 2023 was $4.417B, a 0.14% increase from 2022.
  • Elanco Animal Health annual revenue for 2022 was $4.411B, a 7.41% decline from 2021.
Elanco Animal Health Annual Revenue
(Millions of US $)
2024 $4,439
2023 $4,417
2022 $4,411
2021 $4,764
2020 $3,271
2019 $3,071
2018 $3,067
2017 $2,889
2016 $2,914
2015 $2,909
Elanco Animal Health Quarterly Revenue
(Millions of US $)
2024-12-31 $1,020
2024-09-30 $1,030
2024-06-30 $1,184
2024-03-31 $1,205
2023-12-31 $1,035
2023-09-30 $1,068
2023-06-30 $1,057
2023-03-31 $1,257
2022-12-31 $984
2022-09-30 $1,026
2022-06-30 $1,175
2022-03-31 $1,226
2021-12-31 $1,112
2021-09-30 $1,131
2021-06-30 $1,279
2021-03-31 $1,242
2020-12-31 $1,137
2020-09-30 $890
2020-06-30 $586
2020-03-31 $658
2019-12-31 $787
2019-09-30 $771
2019-06-30 $782
2019-03-31 $731
2018-12-31 $799
2018-09-30 $761
2018-06-30 $770
2018-03-31 $736
2017-12-31
2017-09-30 $697
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $5.492B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Chemed (CHE) United States $8.236B 25.31
Option Care Health (OPCH) United States $5.459B 25.87
RadNet (RDNT) United States $4.453B 98.62
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
U.S Physical Therapy (USPH) United States $1.298B 34.13
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Atai Life Sciences (ATAI) Germany $0.305B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00